CAP

Scifluor Life Sciences names Arthur Hiller CEO

Thursday, June 30, 2011 10:06 AM

SciFluor Life Sciences has appointed Arthur Hiller Chief Executive Officer.

More... »

Medpace sells 80% stake, but bucks the trend of vying for big pharma/CRO partnerships

Monday, June 6, 2011 10:16 AM

Medpace is something of an oddity in this era of medium-sized CROs doing everything in their power to get bigger in the hopes of landing huge strategic partnership contracts with big pharma.

More... »

Sagent adds Mark Kessel as senior advisor

Wednesday, May 4, 2011 01:26 PM

Sagent Pharmaceuticals has appointed Mark Kessel as senior advisor to the firm.  Kessel, a co-founder of Symphony Capital, will assist Sagent's expanding healthcare practice from its New York office.

More... »

Quintiles lab earns CAP accreditation

Tuesday, March 1, 2011 08:54 AM

Quintiles’ central laboratory in Marietta, Ga., has received accreditation from the College of American Pathologists (CAP).

More... »

BioClinica stockholder calls for executives to resign, as CEO says new eclinical push still ramping up

Tuesday, October 26, 2010 09:06 AM

White-hot controversy has been brewing between the imaging-focused CRO/eclinical company BioClinica and one of its investors, Nicusa Capital.

More... »

ClinTec partners with Elephant Capital for Asia Pacific expansion

Thursday, August 19, 2010 10:47 AM

Global CRO ClinTec International has announced a financial and strategic partnership with Elephant Capital, an AIM market-listed private equity firm.  With an investment of approximately $12.5 million, Elephant has acquired a significant minority stake in ClinTec, entering the clinical research base. ClinTec operates as a global provider of outsourcing solutions addressing the drug development lifecycle.

More... »

Covance Launches Discovery and Translational Services Division

Monday, May 17, 2010 12:59 PM

Covance has reorganized its early-stage drug development work into a new division dedicated to discovery services, antibody products and immunology. The new group, Discovery and Translational Services, integrates the CRO’s Biomarker Center for Excellence, formed in 2009, with its Genomics Laboratory and existing partnerships with Caprion Proteomics and Rules-Based Medicine. 

More... »

PPD Profits Fall Short in 2009

Tuesday, February 9, 2010 06:59 AM

PPD’s full-year income from operations fell 32% in 2009, the contract research organization (CRO) reported last night. Revenues for the year were also down from $1.55 billion in 2008 to $1.42 billion.

More... »

PPD Sells Biomarker Business to Caprion

Wednesday, January 27, 2010 07:59 AM

PPD’s plan to refocus its contract research organization (CRO) business is one step closer to final with the recent sale of its biomarker services division, PPD Biomarker Discovery Sciences, to Montreal-based Caprion Proteomics.

More... »

Bio-Imaging Technologies Sells CapMed Division

Thursday, January 8, 2009 09:44 AM

Contract research organization (CRO) Bio-Imaging Technologies has sold off its CapMed division, which provides personal health management solutions to hospitals, employers and pharmaceutical companies, in order to better focus on the CRO’s core clinical trials business.

More... »